scholarly article | Q13442814 |
P356 | DOI | 10.1159/000332014 |
P698 | PubMed publication ID | 22286885 |
P50 | author | Thomas Lengauer | Q1243222 |
Jürgen Rockstroh | Q47006499 | ||
Gerd Fätkenheuer | Q47006694 | ||
Rolf Kaiser | Q115898058 | ||
Mark Oette | Q115914953 | ||
Dieter Häussinger | Q19959784 | ||
P2093 | author name string | Stefan Reuter | |
Heribert Knechten | |||
P2860 | cites work | Ageing with HIV: newly diagnosed older adults in Italy | Q50130779 |
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults | Q50136108 | ||
Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. | Q52919874 | ||
Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV | Q56837870 | ||
No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993–2002) | Q57181176 | ||
Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe | Q58291953 | ||
Changes in thymic function with age and during the treatment of HIV infection | Q59066353 | ||
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
AIDS and the elderly | Q33926249 | ||
Newly diagnosed HIV infections: review in UK and Ireland | Q33940910 | ||
Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements | Q35065073 | ||
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies | Q36285986 | ||
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection | Q36745251 | ||
Pharmacokinetics and drug metabolism in the elderly | Q37514319 | ||
Greater effect of highly active antiretroviral therapy on survival in people aged > or =50 years compared with younger people in an urban observational cohort | Q39639443 | ||
Correlates of lending needles/syringes among HIV-seropositive injection drug users | Q42640169 | ||
HIV transmission and high rates of late diagnoses among adults aged 50 years and over | Q45549222 | ||
Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes | Q45723070 | ||
Clinical experience with human immunodeficiency virus-infected older patients in the era of effective antiretroviral therapy | Q45732541 | ||
Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study | Q45738129 | ||
Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion | Q45868820 | ||
P433 | issue | 2 | |
P304 | page(s) | 147-153 | |
P577 | publication date | 2012-01-24 | |
P1433 | published in | Intervirology | Q15757002 |
P1476 | title | Risk factors associated with older age in treatment-naive HIV-positive patients. | |
P478 | volume | 55 |
Q37196037 | A review of cardiovascular and renal function monitoring: a consideration of older adults with HIV. |
Q35150665 | Acute tubular nephropathy in a patient with acute HIV infection: review of the literature |
Q36206426 | Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution. |
Q47886596 | New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004-15: an analysis of surveillance data |
Q35897165 | Risk factors for mortality during antiretroviral therapy in older populations in resource-limited settings |
Search more.